Evidence map›Paper›PMID 30976789›Full record

ArticleAmerican journal of epidemiology2019

Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study.

Renata Zelic, Daniela Zugna, Matteo Bottai, Ove Andrén, Jonna Fridfeldt, Jessica Carlsson, Sabina Davidsson, Valentina Fiano, Michelangelo Fiorentino, Francesca Giunchi and 8 more

Erratum issuedAbstract read
In one paragraph

Article in American journal of epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Renata ZelicClinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Daniela ZugnaCancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
Matteo BottaiUnit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Ove AndrénDepartment of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Jonna FridfeldtDepartment of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Jessica CarlssonDepartment of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Sabina DavidssonDepartment of Urology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Valentina FianoCancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
Michelangelo FiorentinoPathology Service, Addarii Institute of Oncology, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Francesca GiunchiPathology Service, Addarii Institute of Oncology, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Chiara GrassoCancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
Luca LianasData-Intensive Computing Division, Center for Advanced Studies, Research and Development in Sardinia, Pula, Italy.
Cecilia MasciaData-Intensive Computing Division, Center for Advanced Studies, Research and Development in Sardinia, Pula, Italy.
Luca MolinaroDivision of Pathology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza Hospital, Turin, Italy.
Gianluigi ZanettiData-Intensive Computing Division, Center for Advanced Studies, Research and Development in Sardinia, Pula, Italy.
Lorenzo RichiardiCancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
Andreas PetterssonClinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Olof AkreDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we describe the Prognostic Factors for Mortality in Prostate Cancer (ProMort) study and use it to demonstrate how the weighted likelihood method can be used in nested case-control studies to estimate both relative and absolute risks in the competing-risks setting. ProMort is a case-control study nested within the National Prostate Cancer Register (NPCR) of Sweden, comprising 1,710 men diagnosed with low- or intermediate-risk prostate cancer between 1998 and 2011 who died from prostate cancer (cases) and 1,710 matched controls. Cause-specific hazard ratios and cumulative incidence functions (CIFs) for prostate cancer death were estimated in ProMort using weighted flexible parametric models and compared with the corresponding estimates from the NPCR cohort. We further drew 1,500 random nested case-control subsamples of the NPCR cohort and quantified the bias in the hazard ratio and CIF estimates. Finally, we compared the ProMort estimates with those obtained by augmenting competing-risks cases and by augmenting both competing-risks cases and controls. The hazard ratios for prostate cancer death estimated in ProMort were comparable to those in the NPCR. The hazard ratios for dying from other causes were biased, which introduced bias in the CIFs estimated in the competing-risks setting. When augmenting both competing-risks cases and controls, the bias was reduced.

Indexed as

AgedAge FactorsCase-Control StudiesHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingPrognosisProportional Hazards ModelsProstate-Specific AntigenProstatic NeoplasmsRisk AssessmentRisk FactorsSwedenProstate-Specific Antigenabsolute riskcompeting riskscumulative incidence functionflexible parametric survival modelinverse probability weightingnested case-control studiesweighted likelihood

Identifiers

PMID30976789
PMCPMC8210820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.